rs139576982
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4BS1_Supporting
The NM_020376.4(PNPLA2):c.236G>A(p.Arg79Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000641 in 1,613,886 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_020376.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000466 AC: 71AN: 152208Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000674 AC: 169AN: 250926Hom.: 0 AF XY: 0.000715 AC XY: 97AN XY: 135740
GnomAD4 exome AF: 0.000660 AC: 964AN: 1461560Hom.: 0 Cov.: 32 AF XY: 0.000673 AC XY: 489AN XY: 727064
GnomAD4 genome AF: 0.000466 AC: 71AN: 152326Hom.: 0 Cov.: 33 AF XY: 0.000416 AC XY: 31AN XY: 74488
ClinVar
Submissions by phenotype
Neutral lipid storage myopathy Uncertain:3Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 31, 2022 | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 79 of the PNPLA2 protein (p.Arg79Gln). This variant is present in population databases (rs139576982, gnomAD 0.1%), and has an allele count higher than expected for a pathogenic variant. This missense change has been observed in individual(s) with clinical features of PNPLA2-related conditions (PMID: 32041611). ClinVar contains an entry for this variant (Variation ID: 465789). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). Experimental studies have shown that this missense change affects PNPLA2 function (PMID: 21170305). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | May 13, 2022 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | May 25, 2020 | A heterozygous missense variant was identified, NM_020376.3(PNPLA2):c.236G>A in exon 3 of 10 of the PNPLA2 gene. This substitution is predicted to create a minor amino acid change from arginine to glutamine at position 79 of the protein, NP_065109.1(PNPLA2):p.(Arg79Gln). The arginine at this position has high conservation (100 vertebrates, UCSC), and is located within the Patatin-like phospholipase domain. In silico software predicts this variant to be damaging (Polyphen, SIFT, CADD, Mutation Taster). The variant is present in the gnomAD population database at a frequency of 0.07% (189 heterozygotes, 0 homozygotes). In addition, functional studies show that this variant causes impaired catalytic activity (Coassin, S. et al. (2010)). This variant has not been previously reported in clinical cases. Based on information available at the time of curation, this variant has been classified as a VARIANT of UNCERTAIN SIGNIFICANCE (VUS) with POTENTIAL CLINICAL RELEVANCE. Legend: (P) - Pathogenic, (N) - Neutral, (B) - Benign - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at